OncoCyte Corp/ US68235C2061 /

9/28/2023 8:53:01 PM	Chg. -	Volume	Bid-	Ask-	High	Low
3.19USD	-	8 Turnover: 25.56	-Bid Size: -	-Ask Size: -	3.21	3.19

Newsfile Corp 6/1 Oncocyte Corporation to Present at the LD Micro Invitational XIII

GlobeNewswire 3/28/2022 Oncocyte to Present New Data Confirming Association of IO Score with Response to Immunotherapy Treat...

GlobeNewswire 3/10/2022 Oncocyte Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update

GlobeNewswire 3/1/2022 Oncocyte to Report Fourth Quarter and Full Year 2021 Financial Results on Thursday March 10

GlobeNewswire 2/15/2022 Zynerba Pharmaceuticals Announces Planned Retirement of Suzanne Hanlon and Appoints Albert P. Parker...

GlobeNewswire 1/18/2022 Oncocyte Announces Development and Co-Marketing Agreement with Thermo Fisher Scientific to Expand Ac...

GlobeNewswire 1/4/2022 Oncocyte Announces Peer-Reviewed Publication in Cancers Showing Utility of DetermaCNI™ Blood-Only Mo...

GlobeNewswire 12/11/2021 Annual Changes to the Nasdaq Biotechnology Index

GlobeNewswire 12/10/2021 Spotlight Poster Presentation at San Antonio Breast Cancer Symposium SABCS 2021 Shows Oncocyte’s Det...

GlobeNewswire 12/8/2021 Oncocyte and Burning Rock Complete Technology Transfer Part Two and Prepare for Scaled Distribution ...

GlobeNewswire 12/6/2021 Oncocyte Corporation Hosting Business Update Call

GlobeNewswire 12/2/2021 Oncocyte to Present New Data on DetermaIO Clinical Test for Immunotherapy Response in Triple Negativ...

GlobeNewswire 11/18/2021 The Benchmark Company Announces Its Upcoming 10th Annual One-on-One Discovery Conference

GlobeNewswire 11/9/2021 Oncocyte Reports Third Quarter 2021 Financial Results and Provides Corporate Update

GlobeNewswire 11/9/2021 Progenity Appoints Adi Mohanty as Chief Executive Officer

GlobeNewswire 11/4/2021 Oncocyte Announces the Clinical Launch of DetermaIO Immunotherapy Response Prediction Test

GlobeNewswire 10/27/2021 Oncocyte Strengthens Transplant Intellectual Property Portfolio with US Patent Covering Digital PCR ...

GlobeNewswire 10/26/2021 Oncocyte to Report Third Quarter 2021 Financial Results on Tuesday, November 9th

GlobeNewswire 10/7/2021 Oncocyte Appoints Gisela A. Paulsen as Chief Operating Officer

GlobeNewswire 9/30/2021 Oncocyte Publishes Study Demonstrating Predictive Potential for DetermaIO® Test in Triple Negative B...

GlobeNewswire 9/20/2021 Oncocyte Announces Oral Presentation of New Data on Its DetermaIO™ Immunotherapy Response Test at th...

GlobeNewswire 9/20/2021 Oncocyte Hosting Two-Part Key Opinion Leader Event Series

GlobeNewswire 9/16/2021 Modern Healthcare Recognizes Oncocyte as One of the 2021 Best Places to Work in Healthcare

GlobeNewswire 9/13/2021 Oncocyte to Present New Data on DetermaIO™ from NeoTRIPaPDL1 Trial in Oral Presentation from Late-Br...

GlobeNewswire 9/7/2021 Oncocyte to Participate in the 5th Annual Lake Street Capital Markets Best Ideas Growth Conference